The content discusses a groundbreaking skin biopsy test that can accurately detect an abnormal form of alpha-synuclein in individuals with neurodegenerative disorders like Parkinson's disease. The test, known as Syn-One, identified phosphorylated alpha-synuclein (P-SYN) with 95.5% accuracy in a blinded, multicenter trial. This innovation holds promise for early identification of synucleinopathies and advancing drug development. The study, published in JAMA, highlights the urgent need for reliable diagnostic biomarkers in neurodegenerative diseases, affecting millions of individuals in the United States.
翻譯成其他語言
從原文內容
www.medscape.com
從以下內容提煉的關鍵洞見
by Eve 於 www.medscape.com 03-26-2024
https://www.medscape.com/viewarticle/skin-test-accurately-detects-parkinsons-other-2024a10005nx深入探究